retatrutide clinical trials safety efficacy Retatrutide, an experimental drug currently in Phase 3 trials, is nicknamed the Godzilla of weight-loss jabs because of its potential superior efficacy. Developed by Eli Lilly, is a triple hormone VisualAbstract: Retatrutide reduces body weight
Description
Published December 22, 2025

Lab teams hit the same problems

Common symptoms Dull or throbbing head pain Tension around the temples, forehead, or back of the head Sensitivity to light or sound Nausea or fatigue accompanying the headache Headache triggered by hunger, dehydration, or low blood sugar How common are headaches from GLP-1 treatments

They act on the hypothalamus the brain region that decides whether you're hungry or full and they do it remarkably well

A request to speak with a top F.D.A
doi: 10.3389/fendo.2025.1547920
